Skin & JointLow Risk
SNAP-8
Also known as: Acetyl Octapeptide-3, Leuphasyl
- Half-life:
- N/A (topical)
Administration Routes
topical
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Mechanism of Action
Octapeptide extension of Argireline; competes with SNAP-25 for SNARE complex binding; reduces muscle contraction at neuromuscular junction
An enhanced version of Argireline with two additional amino acids for improved SNARE complex inhibition. More potent wrinkle-relaxing effect for expression lines.
Primary Research Areas
- expression line reduction
- wrinkle depth decrease
- anti-aging skin
Risk Profile
Low Risk
Generally considered lower risk in research contexts. Consult a healthcare professional before use.
Regulatory Status
Research OnlyNot Evaluated by FDA
Cosmetic peptide (acetyl octapeptide-3). SNAP-25 analog sold as topical anti-wrinkle cosmetic ingredient. Not regulated as a drug by FDA. No NDA or IND. Cosmetic use only.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.